Friday 7 June 2002

education sessions

08.30 - 10.00
and
15.45 - 17.15
Leonardo

STEM CELL PLASTICITY
Chairs: W. Fibbe (Leiden University Hospital, Leiden, The Netherlands)
A.M. Gianni (Istituto Nazionale Tumori, Milan, Italy)

MESENCHYMAL STEM CELLS AND HEMATOPOIETIC ENGRAFTMENT
W. Fibbe (Leiden University Hospital, Leiden, The Netherlands)
EX VIVO EXPANSION: CLINICAL RESULTS
J. Reiffers (Hospital Haut Lévêque, Pessac, France)
BONE MARROW STEM CELL PLASTICITY: SOMETHING FOR EVERYONE
M. Alison (ICSM at Hammersmith Campus, London, United Kingdom)

08.30 - 10.00
and
15.45 - 17.15
Caravaggio

CHRONIC MYELOPROLIFERATIVE DISORDERS
Chairs: J.I. Christakis (Theagenion Cancer Centre of Thessaloniki, Thessaloniki, Greece)
J. Kutti (Sahlgrenska University Hospital, Gëteborg, Sweden)

MOLECULAR PATHOGENESIS OF POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA
R.C. Skoda (Basel University Hospital, Basel, Switzerland)
PH-NEGATIVE CHRONIC MYELOPROLIFERATIVE DISORDERS: MOLECULAR AND CLINICAL ASPECTS
N.C.P. Cross (Salisbury District Hospital, Salisbury, United Kingdom)
INDICATIONS FOR STEM CELL TRANSPLANTATION
P. Guardiola (Saint-Louis Hospital, Paris, France)

08.30 - 10.00
and
15.45 - 17.15
Botticelli

INNOVATIVE DIAGNOSTICS IN B CELL MALIGNANCIES
Chairs: R. Foa (Università la Sapienza, Rome, Italy)
E. Macintyre (Hopital Necker Enfants Malades, Paris, France)

MRD ASSESSMENT BY QUANTITATIVE PCR TECHNOLOGY
A. Biondi (University of Milan-Bicocca, Monza, Italy)
PCR-BASED CLONALITY STUDIES FOR EARLY DIAGNOSIS OF LYMPHOPROLIFERATIVE DISORDERS
J.J.M van Dongen (Erasmus University Rotterdam, Rotterdam, The Netherlands)
MOLECULAR CYTOGENETICS
H. Dëhner (University of Ulm, Ulm, Germany)

08.30 - 10.00
and
15.45 - 17.15
Raffaello

PATHOGENESIS OF MYELOMA
Chairs: J.L. Harousseau (University Hospital Nantes, Nantes, France)
J.F. San Miguel (Cytometry Service, Salamanca, Spain)

A MOUSE MODEL FOR IMMUNOTHERAPY OF MYELOMA
B. Bogen (University of Oslo, Oslo, Norway)
INTERACTIONS BETWEEN BONE MARROW STROMA AND MYELOMA
J. Epstein (Myeloma & Transplantation Research Centre, Little Rock, AR, United States of America)
MECHANISMS OF SURVIVAL OF HUMAN MYELOMA-GENES THERAPEUTICAL IMPLICATIONS
R. Bataille (University Hospital Nantes, Nantes, France)

08.30 - 10.00
and
15.45 - 17.15
Tiziano

REGULATION OF GENE EXPRESSION IN HEMATOPOIESIS
Chairs: V. Higgs (The Institute of Cancer Research, London, United Kingdom))
E. Vellenga (University Hospital Groningen, The Netherlands)

TRANSCRIPTIONAL CONTROL OF HEMATOPOIESIS
T. Enver (The Institute of Cancer Research, London, United Kingdom)
CHROMATIN ACCESSIBILITY AND GENE REGULATION IN HEMATOPOIETIC CELL DEVELOPMENT
V. Higgs (John Radcliffe Hospital, Oxford, United Kingdom)

08.30 - 10.00
and
15.45 - 17.15
Tintoretto

RED BLOOD CELLS
Chairs: A. Zanella (Ospedale Maggiore, IRCCS, Milan, Italy)
E.A. Rachmilewitz (The E. Wolfson Medical Centre, Holon, Israel)

SICKLE CELL DISEASE: NEW THERAPEUTIC OPTIONS
D. Loukopoulos (University of Athens, Athens, Greece)
THE ADULT THALASSEMIC PATIENT
M.D. Cappellini (University of Milan, Milan, Italy)
GENETIC DEFECTS OF THE RED CELL MEMBRANE AND OF ERYTHROPOIESIS
J. Delaunay (Hospital de Bicêtre, Le Kremlin-Bicetre, France)

08.30 - 10.00
and
15.45 - 17.15
Giotto

COAGULATION DISORDERS
Chairs: D. Meyer (Hospital Bicetre, Le Kremlin-Bicetre, France)
G. Mariani (Istituto di Clinica Medica e Malattie Cardiovascolari, Palermo, Italy)

THE GENERAL HEMATOLOGIST INTERPRETING COAGULATION TESTS
M. Greaves (University of Aberdeen, Aberdeen, United Kingdom)
ACQUIRED INHIBITORS OF COAGULATION FACTORS
I. Pabinger (Medical Clinic I, Vienna, Austria)
DIC IN THE NEW MILLENNIUM
H. ten Cate (Laboratorium for Experimental Internal Medicine, Amsterdam, The Netherlands)

10.30 - 12.00
and
13.45 - 15.15
Caravaggio

HOT ISSUES IN STEM CELL TRANSPLANTATION
Chairs: M. Boogaerts (University Hospital Leuven, Leuven, Belgium)
W. Arcese (University La Sapienza, Rome, Italy)

UP FRONT TRANSPLANTATION IN CHRONIC MYELOID LEUKEMIA
J.F. Apperley (Imperial College School of Medicine, London, United Kingdom)
IMMUNE RECONSTITUTION AFTER ALLOGENEIC TRANSPLANTATION: CLINICAL AND EXPERIMENTAL FINDINGS
J.J. Cornelissen (Erasmus University, Rotterdam, The Netherlands)
NOVEL TREATMENT IN GRAFT-VERSUS-HOST DISEASE
A. Bacigalupo (Hospital San Martino, Genova, Italy)

10.30 - 12.00
and
13.45 - 15.15
Botticelli

IMMUNO-THERAPY
Chairs: B. Coiffier (Centre Hospitalier Lyon-Sud, Lyon, France)
M. Introna (Dept of Immunology and Cell Biology, Milan, Italy)

MONOCLONAL ANTIBODIES IN LYMPHOMA: CURRENT INDICATIONS
B. Coiffier (Hospital Centre Lyon-Sud, Lyon, France)
ANTIGEN SPECIFIC T CELLS FOR THE TREATMENT OF INFECTIONS AFTER TRANSPLANTATION
H. Einsele (Medical University Clinic, Tübingen, Germany)
DNA VACCINES: STRATEGIES AND ONGOING TRIALS
F.K. Stevenson (Southampton University Hospitals Trust, Southampton, United Kingdom)

10.30 - 12.00
and
13.45 - 15.15
Raffaello

PEDIATRIC HEMATOLOGY
Chairs: G. Masera (Hospital San Gerardo, Monza, Italy)
M. Arico (M. Tettamanti Research Center, Monza, Italy)

RISK-ADAPTED THERAPY: LESSONS FROM CHILDHOOD LEUKEMIA
M. Schrappe (Children's Hospital, Hannover, Germany)
HISTIOCYTIC DISORDERS
M. Aricò (Children's Hospital 'G. Di Cristina', Palermo, Italy)
INHERITED BONE MARROW FAILURE
I. Dokal (Imperial College School of Medicine, London, United Kingdom)

10.30 - 12.00
and
15.45 - 17.15
Tiziano

GENE THERAPY
Chairs: C. Baum (Medizinische Hochschule Hannover, Hannover, Germany)
R. Handin (Brigham and Women's Hospital, Boston, USA)

PROBLEMS AND POSSIBLE SOLUTIONS IN GENE THERAPY OF HUMAN GENETIC DISEASES
C. Baum (Medical School of Hannover, Hannover, Germany)
THE PROMISES IN PATIENTS WITH HEMOPHILIA
G.C. White (University of North Carolina, School of Medicine, Chapel Hill, NC, United States of America)
SAFETY ISSUES
M.J.H. Kenter (Secretary CCMO, The Hague, The Netherlands)

10.30 - 12.00
and
13.45 - 15.15
Tintoretto

PLATELETS
Chairs: V. Vicente (University General Hospital M. Meseguer, Murcia, Spain)
F. Rodeghiero (San Bortolo Hospital, Vicenza, Italy)

THE RISK OF BLEEDING AND THE RISK OF OVER-TREATMENT IN IMMUNE THROMBOCYTOPENIC PURPURA
K. Lechner (University of Vienna, Vienna, Austria)
THE REFRACTORY PLATELET RECIPIENT
P. Rebulla (IRCCS Hospital Maggiore, Milan, Italy)
HEPARIN-INDUCED THROMBOCYTOPENIA
A. Greinacher (Ernst Moritz Arndt University, Greifswald, Germany)

10.30 - 12.00
and
13.45 - 15.15
Giotto

THROMBOSIS
Chairs: G. Leone (Catholic University, Rome, Italy)
B. Brenner (Rambam Medical Centre, Haifa, Israel)

PREDICTING THE RISK OF THROMBOSIS WITH HEMOSTASIS GENE POLYMORPHISMS: FACTS AND FANCIES
D.A. Lane (Imperial College School of Medicine, London, United Kingdom)
ANTIPHOSPHOLIPID SYNDROME: DEFINITION AND TREATMENT
M. Galli (University of Limburg, Maastricht, The Netherlands)
NEW ANTITHROMBOTIC AGENTS (PENTASACCHARIDES, ORAL THROMBIN INHIBITORS)
M.M. Samama (Hotel Dieu Hospital, Paris, France)